258 related articles for article (PubMed ID: 22745830)
21. Mycophenolate mofetil and valsartan inhibit podocyte apoptosis in streptozotocin-induced diabetic rats.
Lv W; Zhang Y; Guan G; Li P; Wang J; Qi D
Pharmacology; 2013; 92(3-4):227-34. PubMed ID: 24158161
[TBL] [Abstract][Full Text] [Related]
22. miR-15b-5p ameliorated high glucose-induced podocyte injury through repressing apoptosis, oxidative stress, and inflammatory responses by targeting Sema3A.
Fu Y; Wang C; Zhang D; Chu X; Zhang Y; Li J
J Cell Physiol; 2019 Nov; 234(11):20869-20878. PubMed ID: 31025335
[TBL] [Abstract][Full Text] [Related]
23. Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production.
Toyonaga J; Tsuruya K; Ikeda H; Noguchi H; Yotsueda H; Fujisaki K; Hirakawa M; Taniguchi M; Masutani K; Iida M
Nephrol Dial Transplant; 2011 Aug; 26(8):2475-84. PubMed ID: 21220752
[TBL] [Abstract][Full Text] [Related]
24. Effects of BSF on Podocyte Apoptosis via Regulating the ROS-Mediated PI3K/AKT Pathway in DN.
Cui FQ; Wang YF; Gao YB; Meng Y; Cai Z; Shen C; Liu ZQ; Jiang XC; Zhao WJ
J Diabetes Res; 2019; 2019():9512406. PubMed ID: 31886291
[TBL] [Abstract][Full Text] [Related]
25. Histone deacetylase 4 mediates high glucose-induced podocyte apoptosis via upregulation of calcineurin.
Shi W; Huang Y; Zhao X; Xie Z; Dong W; Li R; Chen Y; Li Z; Wang W; Ye Z; Liu S; Zhang L; Liang X
Biochem Biophys Res Commun; 2020 Dec; 533(4):1061-1068. PubMed ID: 33019979
[TBL] [Abstract][Full Text] [Related]
26. Silencing of USP22 suppresses high glucose-induced apoptosis, ROS production and inflammation in podocytes.
Shi JX; Wang QJ; Li H; Huang Q
Mol Biosyst; 2016 Apr; 12(5):1445-56. PubMed ID: 26953552
[TBL] [Abstract][Full Text] [Related]
27. 1, 25-dihydroxyvitamin D3 decreases adriamycin-induced podocyte apoptosis and loss.
Zou MS; Yu J; Nie GM; He WS; Luo LM; Xu HT
Int J Med Sci; 2010 Aug; 7(5):290-9. PubMed ID: 20827429
[TBL] [Abstract][Full Text] [Related]
28. The antioxidant silybin prevents high glucose-induced oxidative stress and podocyte injury in vitro and in vivo.
Khazim K; Gorin Y; Cavaglieri RC; Abboud HE; Fanti P
Am J Physiol Renal Physiol; 2013 Sep; 305(5):F691-700. PubMed ID: 23804455
[TBL] [Abstract][Full Text] [Related]
29. Astragalus membranaceus and Panax notoginseng, the Novel Renoprotective Compound, Synergistically Protect against Podocyte Injury in Streptozotocin-Induced Diabetic Rats.
Zhai R; Jian G; Chen T; Xie L; Xue R; Gao C; Wang N; Xu Y; Gui D
J Diabetes Res; 2019; 2019():1602892. PubMed ID: 31179338
[TBL] [Abstract][Full Text] [Related]
30. Astragaloside IV prevents acute kidney injury in two rodent models by inhibiting oxidative stress and apoptosis pathways.
Gui D; Huang J; Liu W; Guo Y; Xiao W; Wang N
Apoptosis; 2013 Apr; 18(4):409-22. PubMed ID: 23325448
[TBL] [Abstract][Full Text] [Related]
31. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
32. Perilipin 5 ameliorates high-glucose-induced podocyte injury via Akt/GSK-3β/Nrf2-mediated suppression of apoptosis, oxidative stress, and inflammation.
Feng J; Xie L; Yu X; Liu C; Dong H; Lu W; Kong R
Biochem Biophys Res Commun; 2021 Mar; 544():22-30. PubMed ID: 33516878
[TBL] [Abstract][Full Text] [Related]
33. Enhanced glycogen synthase kinase-3β activity mediates podocyte apoptosis under diabetic conditions.
Paeng J; Chang JH; Lee SH; Nam BY; Kang HY; Kim S; Oh HJ; Park JT; Han SH; Yoo TH; Kang SW
Apoptosis; 2014 Dec; 19(12):1678-90. PubMed ID: 25284613
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol ameliorates renal damage by inhibiting oxidative stress-mediated apoptosis of podocytes in diabetic nephropathy.
Wang F; Li R; Zhao L; Ma S; Qin G
Eur J Pharmacol; 2020 Oct; 885():173387. PubMed ID: 32710953
[TBL] [Abstract][Full Text] [Related]
35. Experimental study on renoprotective effect of intermedin on diabetic nephropathy.
Wang Y; Tian J; Mi Y; Ren X; Lian S; Kang J; Wang J; Zang H; Wu Z; Yang J; Qiao X; Zhou X; Wang G; Zhou Y; Li R
Mol Cell Endocrinol; 2021 May; 528():111224. PubMed ID: 33675865
[TBL] [Abstract][Full Text] [Related]
36. Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice.
Wang X; Gao Y; Tian N; Zou D; Shi Y; Zhang N
Drug Des Devel Ther; 2018; 12():2431-2442. PubMed ID: 30122901
[TBL] [Abstract][Full Text] [Related]
37. Sp1-mediated upregulation of Prdx6 expression prevents podocyte injury in diabetic nephropathy via mitigation of oxidative stress and ferroptosis.
Zhang Q; Hu Y; Hu JE; Ding Y; Shen Y; Xu H; Chen H; Wu N
Life Sci; 2021 Aug; 278():119529. PubMed ID: 33894270
[TBL] [Abstract][Full Text] [Related]
38. Protective effects of Astragaloside IV on endoplasmic reticulum stress-induced renal tubular epithelial cells apoptosis in type 2 diabetic nephropathy rats.
Ju Y; Su Y; Chen Q; Ma K; Ji T; Wang Z; Li W; Li W
Biomed Pharmacother; 2019 Jan; 109():84-92. PubMed ID: 30396095
[TBL] [Abstract][Full Text] [Related]
39. Notoginsenoside R1 ameliorates podocyte adhesion under diabetic condition through α3β1 integrin upregulation in vitro and in vivo.
Gui D; Wei L; Jian G; Guo Y; Yang J; Wang N
Cell Physiol Biochem; 2014; 34(6):1849-62. PubMed ID: 25503068
[TBL] [Abstract][Full Text] [Related]
40. Astragalosides IV protected the renal tubular epithelial cells from free fatty acids-induced injury by reducing oxidative stress and apoptosis.
Chen Q; Su Y; Ju Y; Ma K; Li W; Li W
Biomed Pharmacother; 2018 Dec; 108():679-686. PubMed ID: 30245468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
